To assess the impact of long-term, low-grade systemic inflammation on endothelial function in psoriasis, many researchers have examined the effects of inflammatory biomarkers, particularly CRP and hsCRP, with conflicting evidence in the literature [12]. This evidence concerns the gene CRP and psoriasis.